On this page
Deflazacort
Active ingredient 9 prescription 20 with labelling
Overview
Source: NDC DirectoryIngredient name
DEFLAZACORT
Base moiety
DEFLAZACORT
RxNorm CUI
UNII
KR5YZ6AE4B
Medication products
10
Brand names
7
Dosage forms
3
FAERS reports
6,359 · not a risk measure
- Deflazacort Powder
- EMFLAZA deflazacort · Suspension
- KYMBEE Deflazacort · Suspension
- PYQUVI deflazacort · Suspension
- Deflazacort Tablet
- Deflazacort Oral Suspension Deflazacort · Suspension
- EMFLAZA deflazacort · Tablet
- JAYTHARI Deflazacort · Tablet
- JAYTHARI Oral Suspension Deflazacort · Suspension
- KYMBEE Deflazacort · Tablet
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Suspension | 5 | EMFLAZA, KYMBEE, PYQUVI, Deflazacort Oral Suspension … |
| Tablet | 4 | Deflazacort, EMFLAZA, JAYTHARI, KYMBEE |
| Powder | 1 | Deflazacort |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |